ArticleLeukemia2022

SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase.

Sandra Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.